chartexchange

Novo Nordisk's weight loss injection cut obesity in young children, trial shows

Quartz | Nov 16, 2026 12:10 PM EST


In the STEP Young trial, BMI fell an estimated 17.4% with semaglutide and rose 2.2% with placebo at week 68 among children 6 to under 12

Read original article